Revenue FY2025
$4.34B
Net Income
$0.85B
EPS (Basic)
$5.47
Net Margin
19.6%
ROE
31.2%
Total Equity
$2.72B
Shares Out
151M
ILLUMINA, INC. — Laboratory Analytical Instruments. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2008–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 9 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Patient Capital Management
Samantha McLemore
$0.06B
2.4%
(36.6%)
WCM Investment Management
WCM Investment Management
$1.12B
1.2%
+4.8%
ARK Investment Management
ARK Investment Management
$0.18B
1.1%
(7.5%)
Century Management
Arnold Van Den Berg
$0.01B
1.1%
(2.6%)
Capital World Investors
Capital World Investors
$2.71B
0.3%
(0.8%)
Renaissance Technologies
Renaissance Technologies
$0.15B
0.2%
(15.0%)
Motley Fool Asset Management
Motley Fool Asset Management
$0.00B
0.0%
(8.2%)
Alps Advisors
Alps Advisors
$0.00B
0.0%
+43.3%
Bridgewater Associates
Bridgewater Associates
$0.00B
0.0%
(1.3%)
Insider Transactions
Reading stored insider transactions…